Drug Database
Back to search

Netherlands· NL-31d61bfea8a5

LysaKare 25 g/25 g oplossing voor infusie

A arginin und lysin product containing argininehydrochloride, (l-) + lysinehydrochloride, l-, registered in Netherlands by Advanced Accelerator Applications SA (AAA). The same ATC class is registered in 8 of our 19 countries.

ATC V03AF11

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLysaKare 25 g/25 g oplossing voor inf…ATCV03AF11REGISTER NO.NL-31d61bfea8a5PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about argininehydrochloride, (l-) + lysinehydrochloride, l-Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Arginin und lysin is registered in 8 of 19 countries.

Countries holding a registration under ATC V03AF11 (arginin und lysin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search arginin und lysin products by name

Arginin und lysin · ATC V03AF11

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ARGININEHYDROCHLORIDE, (L-) + LYSINEHYDROCHLORIDE, L-
Manufacturer
Advanced Accelerator Applications SA (AAA)
Country
Netherlands (NL)
ATC code
V03AF11
ATC class
Arginin und Lysin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/19/1381

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V03AF11

Arginin und lysin, as other registers publish it.

All arginin und lysin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/42be5492-fb85-4ef2-b22a-28353bfa9f59
GET /v1/drugs/42be5492-fb85-4ef2-b22a-28353bfa9f59?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/lysakare-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Arginine and lysine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp123284",
  "excipients": [
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ARGININEHYDROCHLORIDE, (L-)",
    "LYSINEHYDROCHLORIDE, L-"
  ],
  "leaflet_url": null,
  "authorised_at": "2019/07/25",
  "procedure_number": "EMEA/H/C/004541",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/19/1381",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about arginin und lysin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console